New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 8, 2013
18:45 EDTJNJJ&J's siltuximab improves symptoms in Castleman disease, Bloomberg says
In a clinical trial, Johnson & Johnsonís experimental drug siltuximab, which is a a monoclonal antibody, improved symptoms and shrank growths in patients with Castleman disease, says Bloomberg. Castleman disease is a rare condition marked by enlarged lymph nodes with no approved therapies, added Bloomberg. Reference Link
News For JNJ From The Last 14 Days
Check below for free stories on JNJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
11:41 EDTJNJCubist rises after report sparks takeover interest speculation
Subscribe for More Information
August 12, 2014
09:35 EDTJNJActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GOOG C TSL EXAS BAC DNDN JNJ TSLA
August 8, 2014
09:01 EDTJNJJohnson & Johnson remains undervalued, says Cowen
Subscribe for More Information
August 6, 2014
06:21 EDTJNJPiper Jaffray to hold a summit
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use